[Pertuzumab (PERJETA(®) intravenous infusion 420 mg/14 mL): pharmacological properties and clinical development overview].

Myobudani Hiroshi, Ushiyama Naomi, Ichinose Ryota, Takasuka Tsuyoshi

Nihon Yakurigaku Zasshi. 2014 Feb;143(2):95-102. doi: 10.1254/fpj.143.95.

Abstract

摘要

相似文献

Nihon Yakurigaku Zasshi. 2014 Feb;143(2):95-102. doi: 10.1254/fpj.143.95.

Prescrire Int. 2015 Apr;24(159):93.

Bull Cancer. 2014 Jul-Aug;101(7-8):765-71. doi: 10.1684/bdc.2014.1940.

Am J Health Syst Pharm. 2013 Sep 15;70(18):1579-87. doi: 10.2146/ajhp120735.

J Pharm Sci. 2013 Mar;102(3):794-812. doi: 10.1002/jps.23403. Epub 2012 Dec 5.

Prescrire Int. 2013 Feb;22(135):39.

Med Lett Drugs Ther. 2021 Mar 8;63(1619):e43-e44.

Farm Hosp. 2014 May 1;38(3):254-5. doi: 10.7399/fh.2014.38.3.1169.

Pharmacotherapy. 2014 Jan;34(1):60-71. doi: 10.1002/phar.1338. Epub 2013 Aug 5.

Med Lett Drugs Ther. 2013 Sep 16;55(1425):75-6.

Health Sci Rep. 2022 Jun 3;5(4):e673. doi: 10.1002/hsr2.673. eCollection 2022 Jul.

20分钟写一篇综述，助力文献阅读效率提升50倍。

大模型驱动的PubMed中文搜索引擎

学术文献翻译模型，支持多种主流文档格式。